In these studies, the histology-related inclusion criteria were different; in general, the studies included high-grade B-cell lymphoma (HGBCL) with or without translocations of MYC and BCL2 and/or BCL6 (double/triple-hit lymphoma) and transformed follicular lymphoma (tFL). The gene discussed is BCL6; the disease is B-cell non-Hodgkin lymphoma.